eMedicine Specialties > Dermatology > Internal Medicine

Acrokeratosis Neoplastica

Author: Daniel D Bennett, MD, Assistant Professor, Department of Internal Medicine, Texas A&M Health Science Center College of Medicine; Senior Staff, Department of Dermatology, Scott and White Memorial Hospital
Contributor Information and Disclosures

Updated: Jul 28, 2008

Introduction

Background

Acrokeratosis neoplastica (AN) is a rare acral psoriasiform dermatosis associated with internal malignancy, most frequently squamous cell carcinoma (SCC) of the upper aerodigestive tract. The syndrome typically precedes the diagnosis of malignancy.

The term Bazex syndrome describes 2 different entities, both described by Bazex and colleagues: AN and the genetic syndrome of basal cell carcinomas, follicular atrophoderma, hypotrichosis, and disorders of sweating.

The Medscape Head and Neck Cancer Resource Center and the eMedicine article Squamous Cell Carcinoma may be of interest.

Pathophysiology

The pathophysiology of AN is not understood. Proposed mechanisms include cross-reactivity between skin and tumor antigens, the action of tumor-produced growth factors, and even zinc deficiency.1

Frequency

United States

Approximately 140 cases have been reported in the literature.2

Mortality/Morbidity

Mortality and morbidity are related directly to the underlying neoplasm. The skin lesions of AN rarely improve without successful treatment of the underlying malignancy.3

Sex

In one review, only 12 of 140 cases were in women.2

Age

In one review, the mean age of onset was 61 years.3

Clinical

History

  • Patients present with asymptomatic, acrally located psoriasiform or hyperpigmented lesions. The lesions are treatment resistant.
  • As the tumor progresses, the lesions of AN may spread and may involve the cheeks, elbows, knees, and trunk.
  • In one review, when skin findings preceded the diagnosis of malignancy, they were present for an average of 1 year.3
  • The physician should inquire regarding risk factors for malignancy, including smoking habit, alcohol consumption, and family history. Upon further questioning, patients may admit to mild constitutional symptoms, weight loss, and other nonspecific findings of internal malignancy.

Physical

  • Cutaneous manifestations of AN are as follows:
    • Symmetrical, acral, scaly, red-to-violaceous plaques or patches
    • Involvement of the fingers, distal hands, feet, nose, and helices of the ears: Isolated involvement of the helices is particularly suggestive of AN.
    • Involvement of the cheeks, trunk, elbows, knees, palms, and soles in advanced disease
    • Nail dystrophy
    • Swelling of the digits with a blue-to-violet discoloration
    • Acrally distributed, hyperpigmented patches possible in persons with darker skin types
    • Bullae of the hands and feet
  • Other physical examination findings suggesting paraneoplasia are as follows:
    • Ichthyosis
    • Pruritus
    • Sign of Leser-Trélat
    • Clubbing
    • Dermatomyositis
  • A complete physical examination should be performed in all patients. This should include a thorough head and neck examination, including endoscopic examination, and pelvic examination in women.3

Causes

  • Most AN cases are associated with SCC of the upper one third of the respiratory or GI tracts (ie, oropharynx/larynx, lungs, esophagus).
  • Case reports also describe SCC of the thymus, vulva, and skin and of SCC with an unknown primary tumor.
  • Other reported associated tumors include poorly differentiated carcinoma, adenocarcinoma of multiple primary sites, small cell carcinoma of the lung, lymphoma, ductal carcinoma of the breast, carcinoid, multiple myeloma, transitional cell carcinoma of the bladder, well-differentiated thymic carcinoma, and cholangiocarcinoma.2

More on Acrokeratosis Neoplastica

Overview: Acrokeratosis Neoplastica
Differential Diagnoses & Workup: Acrokeratosis Neoplastica
Treatment & Medication: Acrokeratosis Neoplastica
Follow-up: Acrokeratosis Neoplastica
Multimedia: Acrokeratosis Neoplastica
References

References

  1. Taher M, Grewal P, Gunn B, Tonkin K, Lauzon G. Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zinc. J Cutan Med Surg. Mar-Apr 2007;11(2):78-83. [Medline].

  2. Karabulut AA, Sahin S, Sahin M, Eksioglu M, Ustün H. Paraneoplastic acrokeratosis of Bazex (Bazex's syndrome): report of a female case associated with cholangiocarcinoma and review of the published work. J Dermatol. Dec 2006;33(12):850-4. [Medline].

  3. Bolognia JL. Bazex syndrome: acrokeratosis paraneoplastica. Semin Dermatol. Jun 1995;14(2):84-9. [Medline].

  4. Valdivielso M, Longo I, Suárez R, Huerta M, Lázaro P. Acrokeratosis paraneoplastica: Bazex syndrome. J Eur Acad Dermatol Venereol. May 2005;19(3):340-4. [Medline].

Further Reading

Keywords

acrokeratosis neoplastica, keratosis, Bazex syndrome, paraneoplastic acrokeratosis

Contributor Information and Disclosures

Author

Daniel D Bennett, MD, Assistant Professor, Department of Internal Medicine, Texas A&M Health Science Center College of Medicine; Senior Staff, Department of Dermatology, Scott and White Memorial Hospital
Daniel D Bennett, MD is a member of the following medical societies: American Academy of Dermatology, American Contact Dermatitis Society, American Medical Association, Dermatology Foundation, National Psoriasis Foundation, Society for Investigative Dermatology, and Texas Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Jean-Hilaire Saurat, MD, Chair, Professor, Department of Dermatology, University of Geneva, Switzerland
Jean-Hilaire Saurat, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: 3M Pharmaceutical Grant/research funds Other; Graceway Pharmaceuticals Grant/research funds Other

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.